title: Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells.
authors.affiliation: Division of Hematology & Oncology, Department of Internal Medicine, UC Davis Cancer Center, Sacramento, California 95817, USA.
authors.forename: Sisi
authors.initials: S
authors.lastname: Wang
authors.forename: Hongyong
authors.initials: H
authors.lastname: Zhang
authors.forename: Michael
authors.initials: M
authors.lastname: Malfatti
authors.forename: Ralph
authors.initials: R
authors.lastname: de Vere White
authors.forename: Primo N
authors.initials: PN
authors.lastname: Lara
authors.forename: Kenneth
authors.initials: K
authors.lastname: Turteltaub
authors.forename: Paul
authors.initials: P
authors.lastname: Henderson
authors.forename: Chong-xian
authors.initials: CX
authors.lastname: Pan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000633:toxicity*; D016190:Carboplatin / Q000008:administration & dosage / Q000032:analysis / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity*; D045744:Cell Line, Tumor; D018736:DNA Adducts / Q000032:analysis* / Q000737:chemistry; D004260:DNA Repair; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity; D019008:Drug Resistance, Neoplasm; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D000093542:Gemcitabine
chemical_list: D018736:DNA Adducts; C096276:carboplatin-DNA adduct; D003841:Deoxycytidine; D016190:Carboplatin; D000093542:Gemcitabine